Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.003 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 841-860 of 927 (Search time: 0.015 seconds).

Publication YearTitleAuthor(s)
841Nov-2018The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.Ren, Shengxiang; Tian, Qinrui; Amar, Nadav; Yu, Hui; Rivard, Christopher J; Caldwell, Charles; Ng, Terry L; Tu, Megan; Liu, Yiwei; Gao, Dexiang; Ellison, Kim; Suda, Kenichi; Rozeboom, Leslie; Rivalland, Gareth; Mitchell, Paul L R ; Zhou, Caicun; Hirsch, Fred R
84224-Oct-2017The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M; Raraty, Michael; Jackson, Richard; Melling, James; Jones, Owain; Palmer, Daniel H; Cox, Trevor F; Smith, Chloe J; O'Reilly, Derek A; Izbicki, Jakob R; Scarfe, Andrew G; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David; Padbury, Robert; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Anthoney, Alan; Lerch, Markus M; Mayerle, Julia; Oláh, Attila; Rawcliffe, Charlotte L; Campbell, Fiona; Strobel, Oliver; Büchler, Markus W; Neoptolemos, John P
84318-Sep-2018The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.Osborne, Joanne M; Flight, Ingrid; Wilson, Carlene J ; Chen, Gang; Ratcliffe, Julie; Young, Graeme P
8442019The Impact of Universal Immunohistochemistry on Lynch Syndrome Diagnosis in an Australian Colorectal Cancer Cohort.Loh, Zoe ; Williams, David S ; Salmon, Lucinda ; Dow, Eryn; John, Thomas 
84521-Jul-2018The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds.Mazza, Danielle; Lin, Xiaoping; Walter, Fiona M; Young, Jane M; Barnes, David J; Mitchell, Paul L R ; Brijnath, Bianca; Martin, Andrew; Emery, Jon D
8469-Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.Minson, Adrian G; Cummins, Katherine; Fox, Lucy; Costello, Ben; Yeung, David; Cleary, Rebecca; Forsyth, Cecily; Tatarczuch, Maciek; Burbury, Kate; Motorna, Olga; Shortt, Jake; Fleming, Shaun; McQuillan, Andrew; Schwarer, Anthony; Harrup, Rosemary; Holmes, Amy; Ratnasingam, Sumita; Chan, Kah-Lok; Hsu, Wei-Hsun; Ashraf, Asma; Putt, Faye; Grigg, Andrew P 
847Dec-2018The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.Willcox, Abbey ; Wong, Eric ; Nath, Christa; Janson, Brett; Harrison, Simon J; Hoyt, Rosemary; Bajel, Ashish; Shaw, Peter; Ritchie, David; Grigg, Andrew P 
8482020The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].Clarke, Stephen John; Burge, Matthew; Feeney, Kynan; Gibbs, Peter; Jones, Kristian; Marx, Gavin; Molloy, Mark P; Price, Timothy; Reece, William H H; Segelov, Eva; Tebbutt, Niall C 
849Jul-2018The relationship between anticipated response and subsequent experience of cancer treatment-related side effects: A meta-analysis comparing effects before and after treatment exposure.Fletcher, Chloe; Wilson, Carlene J ; Hutchinson, Amanda D; Grunfeld, Elizabeth Alice
850Mar-2019The role of rehabilitation in patients undergoing oesophagectomy for cancer and pre-malignant disease: A qualitative exploration of the views of patients, carers and healthcare providers.Bull, Jeff; Oster, Candice; Flight, Ingrid; Wilson, Carlene J ; Koczwara, Bogda; Watson, David I; Bright, Tim
8511-Jun-2020The role of social norms in the relationship between anti-smoking advertising campaigns and smoking cessation: a scoping review.Dono, Joanne; Miller, Caroline; Ettridge, Kerry; Wilson, Carlene J 
852Aug-2019The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia.Mileshkin, Linda; Dunn, Catherine; Cross, Hannah; Duffy, Mary; Shaw, Mark; Antippa, Phillip; Mitchell, Paul L R ; Akhurst, Tim; Conron, Matthew; Moore, Melissa; Philip, Jenny; Bartlett, James; Emery, Jon; Zambello, Belinda
853Nov-2022Therapeutic drug monitoring in oncology - What's out there: A bibliometric evaluation on the topic.Stojanova, Jana; Carland, Jane E; Murnion, Bridin; Seah, Vincent; Siderov, Jim ; Lemaitre, Florian
854Jun-2020‘This is uncharted water for all of us’: challenges anticipated by hospital clinicians when voluntary assisted dying becomes legal in VictoriaKo, Danielle ; Detering, Karen M ; Sellars, Marcus ; McDougall, Rosalind; Hayes, Barbara; Pratt, Bridget; Hutchinson, Anastasia; Tacey, Mark A ; Shadbolt, Cade
85519-Mar-2020Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients with Elevated CEA.Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; De Gramont, Aimery; Shi, Qian; Overman, Michael James
8561-Nov-2020Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA.Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; Gramont, Aimery De; Shi, Qian; Overman, Michael James
8571-May-2014Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.Arumugaswamy, A; He, S ; Quach, H; Brotchie, J; Grigg, Andrew P 
858Jan-2017Timely initiation of chemotherapy: a systematic literature review in six priority cancers - results and recommendations for clinical practiceAlexander, Marliese; Blum, Robert; Burbury, Kate; Coutsouvelis, John; Dooley, Michael J; Fazil, Obaid; Griffitths, Tina; Ismail, Huda; Joshi, Sachin; Love, Natalie; Opat, Stephen; Parente, Phillip; Porter, Nicole; Ross, Eldene; Siderov, Jim ; Thomas, Pauline; White, Shane ; Kirsa, Sue; Rischin, Danny
859Jun-2022To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy-confirmed versus radiologically-diagnosed primary lung cancer in a single Australian institution.Koh, Tze Lui ; Ong, Wee Loon ; Farrugia, Briana; Leong, Tracy L ; Lapuz, Carminia ; Lim, Adeline 
8601-Sep-2005Towards individualised radiotherapy for Stage I seminoma.Martin, Jarad M; Joon, Daryl Lim; Ng, Nicole; Grace, Michael; Gelderen, David Van; Lawlor, Marita ; Wada, Morikatsu ; Joon, Michael Lim; Quong, George; Khoo, Vincent